Cathepsin S activity is detectable in human keratinocytes and is selectively upregulated upon stimulation with interferon-γ

Journal of Investigative Dermatology

Volumn 119, Issue 1, 2002, Pages 44-49

  Schwarz, Gerold ^a   Boehncke, Wolf Henning ^b   Braun, Manuela ^a   Schröter, Christian J ^a   Burster, Timo ^a   Flad, Thomas ^a   Dressel, Daniela ^a   Weber, Ekkehard ^c   Schmid, Heide ^a   Kalbacher, Hubert ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b GOETHE UNIVERSITY MEDICAL SCHOOL   (Germany)

^c MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Antigen presentation; Antigen processing; Cathepsins B, L, S; Psoriasis

Indexed keywords

CATHEPSIN S; COUMARIN DERIVATIVE; CYTOKINE; GAMMA INTERFERON;

ANTIGEN PRESENTATION; B LYMPHOCYTE; CATALYSIS; CELL ASSAY; CELL LINE; CELL STIMULATION; CONFERENCE PAPER; CONTROLLED STUDY; ENDOSOME; ENZYME ACTIVITY; ENZYME ANALYSIS; EPSTEIN BARR VIRUS; FLUOROMETRY; HUMAN; HUMAN CELL; HYDROLYSIS; INFLAMMATION; KERATINOCYTE; LYSOSOME; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INDUCTION; UPREGULATION;

EID: 18644380025     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2002.01800.x     Document Type: Article

References (36)

1. Abrahamson M: Cystatins. Methods Enzymol 244:685-700, 1994
2. Albanesi C, Cavani A, Girolomini G: Interferon-γ-stimulated human keratinocytes express the genes necessary for the production of peptide-loaded MHC class II molecules. J Invest Dermatol 110:138-142, 1998
3. Authier F, Posner BI, Bergeron JJM: Endosomal proteolysis of internalized proteins. FEBS Lett 389:55-60, 1996
4. Baird J, Lazarus GS, Belip D, Vassejli JD, Busso N, Gubler P, Jensen PJ: mRNA for tissue-type plasminogen activator is present in lesional epidermis from patients with psoriasis, pemphigus, or bullous pemphigoid, but is not detected in normal epidermis. J Invest Dermatol 95:548-552, 1990
5. Boehncke W-H: Psoriasis and bacterial superantigens-Formal or causal correlation? Trends Microbiol 4:485-489, 1996
6. Bos JD, Kapsenberg ML: The skin immune system. Immunol Today 7:235-240, 1986
7. Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A, Fusenig NE: Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 106:761-771, 1988
8. Diment S: Different roles for thiol and aspartyl proteases in antigen presentation of ovalbumin. J Immunol 145:417-422, 1990
9. Fineschi B, Miller J: Endosomal proteases and antigen processing. Trends Biochem Sci 22:377-382, 1997
10. Germain RN: MHC-dependent antigen processing and peptide presentation: Providing ligands for T lymphocyte activation. Cell 76:287-299, 1994
11. Gottlieb AB, Lifshitz B, Fu SM, Staiano-Coico L, Wang CY, Carter DM: Expression of HLA-DR molecules by keratinocytes, and presence of Langerhans cells in the dermal infiltrate of active psoriatic plaques. J Exp Med 164:1013-1028, 1986
12. Hanada K, Tamai M, Ohmura S, Sawada J, Seki T, Tanaka I: Isolation and characterization of E-64, a new thiol protease inhibitor. Agric Biol Chem 42:523-528, 1978
13. Kawada A, Hara K, Kominami E, Hiruma M, Noguchi H, Ishibashi A: Processing of cathepsins L, B and D in psoriatic epidermis. Arch Dermatol Res 289:87-93, 1997
14. Kerr L-AP, Navsaria HA, Barker JNWN, Sakkas LI, Leigh IM, MacDonald DM, Welsh KI: Interferon-gamma activates co-ordinate transcription of HLA-DR, DQ, and DP genes in cultured keratinocytes and requires de novo protein synthesis. J Invest Dermatol 95:653-656, 1990
15. Kirschke H, Schmidt I, Wiederanders B: Cathepsin S. The cysteine proteinase from bovine lymphoid tissue is distinct from cathepsin L (EC 3.4.22.15). Biochem J 240:455-459, 1986
16. Kirschke H, Wiederanders B, Brömme D, Rinne A: Cathepsin S from bovine spleen. Purification, distribution, intracellular localization and action on proteins. Biochem J 264:467-473, 1989
17. Matsunuga Y, Saibara T, Kido H, Katunuma N: Participation of cathepsin B in processing of antigen presentation to MHC class II. FEBS Lett 324:325-330, 1993
18. Meier F, Nebit M, Hsu MY, et al: Human melanoma progression in skin reconstructs. Am J Pathol 156:193-200, 2000
19. Morita T, Kato H, Iwanaga S, Takada K, Kimura T, Sakakibara S: New fluorogenic substrates for α-thrombin, factor Xa, kallikreins and urokinase. J Biochem 82:1495-1498, 1977
20. Nakagawa TY, Rudensky AY: The role of lysosomal proteinases in MHC class II-mediated antigen processing and presentation. Immunol Rev 172:121-129, 1999
21. Nickoloff BJ, Turka LA: Immunological functions of non-professional antigen-presenting cells: New insights from studies of T-cell interactions with keratinocytes. Immunol Today 15:464-469, 1994
22. Palmer JT, Rasnick D, Klaus JL, Brömme D: Vinyl sulfones as mechanism-based cysteine protease inhibitors. J Med Chem 38:3193-3196, 1995
23. Prinz J-C, Vollmer S, Boehncke W-H, Menssen A, Laisney I, Trommler P: Selection of conserved TCR-VDJ-rearrangements in chronic psoriatic plaques indicates a common antigen in psoriasis vulgaris. Eur J Immunol 29:3360-3368, 1999
24. Rheinwald JG, Green H: Formation of a keratinizing epithelium in culture by a cloned cell line derived from a teratoma. Cell 6:331-344, 1975
25. Riese JR, Wolf PR, Brömme D, Natkin LR, Villadangos JA, Ploegh HL, Chapman HA: Essential role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading. Immunity 4:357-366, 1996
26. Schmid H, Lindmeier I, Schmitt H, Eissele R, Neuhaus G, Wehrmann M: Nephrotoxicity of cyclosporin A in the rat. II. Reversible changes in intranephronal and urinary activities of N-acetyl-β-D-glucosaminidase. Renal Physiol Biochem 16:222-232, 1993
27. Schmid H, Koop M, Utermann S, Lambacher L, Mayer P, Schaefer L: Specific catalytic activity of cathepsin S in comparison to cathepsins B and L along the rat nephron. Biol Chem 378:61-69, 1997
28. Schröter CJ, Braun M, Englert J, Beck H, Schmid H, Kalbacher H: A rapid method to separate endosomes from lysosomal contents using differential centrifugation and hypotonic lysis of lysosomes. J Immunol Methods 227:161-168, 1999
29. Shi G-P, Webb AC, Foster KE, Knoll JHM, Lemere CA, Munger JS, Chapman HA: Human cathepsin S. chromosomal localization, gene structure, and tissue distribution. J Biol Chem 269:11530-11536, 1994
30. Szabo SK, Hammerberg C, Yoshida Y, Bata-Csorgo Z, Cooper KD: Identification and quantification of interferon-γ producing T cells in psoriatic lesions: Localization to both CD4+ and CD8+ subsets. J Invest Dermatol 111:1072- 1078, 1998
31. Takahashi H, Cease KB, Berzofsky JA: Identification of proteases that process distinct epitopes on the same protein. J Immunol 142:2221-2229, 1989
32. Towatari T, Nikawa T, Murata M, Yokoo C, Tamai M, Hanada K, Katunuma N: Novel epoxysuccinyl peptides. A selective inhibitor of cathepsin B in vivo. FEBS Lett 280:311-315, 1991
33. Van Noort JM, van der Drift ACM: The selectivity of cathepsin D suggests an involvement of the enzyme in the generation of T-cell epitopes. J Biol Chem 264:14159-14164, 1989
34. Villadangos JA, Bryant RAR, Deussing J, et al: Proteases involved in MHC class II antigen presentation. Immunol Rev 172:109-120, 1999
35. Villadangos JA, Riese RJ, Peters C, Chapman HA, Ploegh HL: Degradation of mouse invariant chain: Roles of cathepsins S and D and the influence of major histocompatibility complex polymorphism. J Exp Med 186:549-560, 1997
36. Wiedow O, Wiese F, Streit V, Kalm C, Christophers E: Lesional elastase activity in psoriasis, contact dermatitis and atopic dermatitis. J Invest Dermatol 99:306-309, 1992